Event Details

November 01, 2018

Description

Mexican government released list of 38 approved OTC cannabis products

Participants (1)

Name Type Mentions
ICA organization 1597 View Entity

Source Documents (1)

HOUSE_OVERSIGHT_024901.jpg

Market Research Report / Investment Analysis • 2.05 MB
View

This document is page 85 of a Cowen Collaborative Insights market research report dated February 25, 2019, analyzing the cannabis industry in Latin America. It details regulatory frameworks, market opportunities, and corporate activities (including JVs and licensing) for companies like Aurora, Khiron Life Sciences, and Pharamacielo in Colombia, Mexico, and Uruguay. The document bears a 'HOUSE_OVERSIGHT_024901' Bates stamp, indicating it was part of a document production for a US House Oversight Committee investigation.

Related Events

Events with shared participants

Acquisition of Interlace Medical by Hologix

Date unknown • N/A

View

Projected legalization of cannabis for adult-use purposes

2019-01-01 • Mexico

View

Supreme Court decision regarding the broadcasting of Carlin's routine on Pacifica radio.

Date unknown • USA

View

Arizona Republican Party enacts a resolution declaring the US a 'Christian Nation'.

Date unknown • Arizona

View

First Iraq War

1990-01-01 • Iraq

View

Set up a Family Assistance Hotline within 10 days via an outsourcer

2005-01-01 • USA

View

Formation of Saudi American Bank

1980-01-01 • Saudi Arabia

View

FDA accepted GW Pharmaceuticals’ New Drug Application (NDA) for the cannabis-derived drug Epidiolex.

2017-10-01 • USA

View

Fundraising campaign in Saudi Arabia for Al Quds uprising (Intifada)

2000-01-01 • Saudi Arabia

View

Employment of Ahmed Nur Ali Jumale

1979-01-01 • Unspecified

View

Event Metadata

Type
Unknown
Location
Mexico
Significance Score
5/10
Participants
1
Source Documents
1
Extracted
2025-11-19 22:01

Additional Data

Source
HOUSE_OVERSIGHT_024901.jpg
Date String
November 2018

Discussion 0

Sign in to join the discussion

No comments yet

Be the first to share your thoughts on this epstein event